Cargando…
Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy
BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Among its subtypes, non-small cell lung cancer (NSCLC) is the most common. Recently, the mitochondrial isoform of the enzyme phosphoenolpyruvate carboxykinase (HsPEPCK-M) was identified as responsible for the metabolic a...
Autores principales: | Baptista, Luiz Phillippe R, Sinatti, Vanessa VC, Da Silva, Joao HM, Dardenne, Laurent Emmanuel, Guimarães, Ana Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689533/ https://www.ncbi.nlm.nih.gov/pubmed/31496750 http://dx.doi.org/10.2147/AABC.S197119 |
Ejemplares similares
-
PEPCK in cancer cell starvation
por: Leithner, Katharina
Publicado: (2015) -
Gluconeogenesis and PEPCK are critical components of healthy aging and dietary restriction life extension
por: Onken, Brian, et al.
Publicado: (2020) -
Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
por: Hyroššová, Petra, et al.
Publicado: (2022) -
Decarboxylation mechanisms of C4 photosynthesis in Saccharum spp.: increased PEPCK activity under water-limiting conditions
por: Cacefo, Viviane, et al.
Publicado: (2019) -
Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195
por: Yang, Won-Mo, et al.
Publicado: (2017)